NEW DELHI — India says it will lift a ban on some drug exports, including hydroxychloroquine, after President Donald Trump threatened retaliation if India failed to send the anti-malarial drug to the United States.
Foreign ministry spokesman Anurag Srivastava said in a statement Tuesday that having confirmed sufficient supplies for India’s needs, export restrictions “have been largely lifted.”
The White House has been championing hydroxychloroquine as a treatment for COVID-19, even though it hasn’t been proven effective against the disease. The drug is officially approved in the U.S. for treating malaria, rheumatoid arthritis and lupus, and experts warn it can cause heart rhythm problems.
Mr. Trump has said that he spoke to Indian Prime Minister Narendra Modi last week about lifting the ban, and in a news conference Monday said that he would be surprised if Mr. Modi didn’t comply.
“If he doesn’t allow it to come out, that would be OK, but of course there may be retaliation. Why wouldn’t there be?” Mr. Trump said.

This story was originally published with images that are no longer available.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.